Concern of a bacteria contamination has pushed McNeil Consumer Healthcare (a Johnson & Johnson company) along with the U.S. Food and Drug Administration to issue a voluntary recall of several types of Children’s TYLENOL.
An electronic letter dated September 18 states:
The company has implemented this recall because examination of bulk raw material detected that one of the inactive ingredients did not meet internal testing requirements. Specifically, the gram-negative bacteria Burkholderia cepacia (B. cepacia) was detected.
The bacteria can be potentially harmful to those with compromised immune systems and chronic conditions such as cystic fibrosis and pulmonary disease.